Related Experiment Video
Updated: Sep 27, 2025

07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
18.8K
Brain metastases: Not all tumors are created equal
Daniel Kirschenbaum1, Ido Amit1
1Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
Neuron
|April 7, 2022
Summary
Cancer spread (metastases) is a leading cause of death. A new study analyzed gene expression in single brain metastatic cells, revealing unique and common features across different primary tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Metastases are the primary cause of cancer-related mortality.
- Understanding the molecular mechanisms of brain metastases is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the gene expression profiles of single cells within brain metastases.
- To identify common and distinct molecular features of brain metastases originating from various primary tumor types.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) was employed to profile gene expression.
- Analysis of metastatic tumor cells and their microenvironment (niche) in brain metastases.
Main Results:
- Distinctive gene expression patterns were observed within brain metastases.
- Shared molecular features were identified across metastases from different primary tumor origins.
- The study characterized both the metastatic cells and their surrounding niche.
Conclusions:
- Single-cell analysis provides novel insights into the heterogeneity of brain metastases.
- Identifying shared and distinct features can inform the development of broadly applicable or specific therapeutic strategies for brain metastases.
Related Concept Videos
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K

